Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.

@article{Rebarber2007IncreasedIO,
  title={Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.},
  author={Andrei Rebarber and Niki B Istwan and Karen Russo-Stieglitz and Jane Cleary-Goldman and Debbie J Rhea and Gary J Stanziano and Daniel H. Saltzman},
  journal={Diabetes care},
  year={2007},
  volume={30 9},
  pages={2277-80}
}
OBJECTIVE Progesterone has a known diabetogenic effect. We sought to determine whether the incidence of gestational diabetes mellitus (GDM) is altered in women receiving weekly 17alpha-hydroxyprogesterone caproate (17P) prophylaxis for the prevention of recurrent preterm birth. RESEARCH DESIGN AND METHODS Singleton gestations in women having a history of preterm delivery were identified from a database containing prospectively collected information from women receiving outpatient nursing… CONTINUE READING